The issue of medication abortion was back before a New Orleans-based appeals court on Wednesday, in the latest iteration of a years-long legal effort to end the provision of abortion drugs via telehealth.

The 5th Circuit Court of Appeal in Louisiana will hear arguments on Wednesday in a case that could decide future telehealth access to mifepristone.

The 5th Circuit will hear Louisiana’s challenge to Biden-era abortion by mail rules as the FDA conducts a new mifepristone safety review.